ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Rasagiline Mesylate Tablets Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-14O8093
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Rasagiline Mesylate Tablets Market Insights Forecast to 2028
BUY CHAPTERS

Global Rasagiline Mesylate Tablets Market Research Report 2025

Code: QYRE-Auto-14O8093
Report
July 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Teva Pharmaceutical
Lundbeck
Sun Pharmaceutical
Apotex
Taj Pharma
Mylan NV
Takeda Pharmaceutical
Sandoz Inc
Intas Pharmaceuticals
Natco Pharma
Ajanta Pharma
Orchid Pharma
Alkem Laboratories

Rasagiline Mesylate Tablets Market

The global market for Rasagiline Mesylate Tablets was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Rasagiline Mesylate Tablets (Azilect) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson"s disease or as an adjunct therapy in more advanced cases.
North American market for Rasagiline Mesylate Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Rasagiline Mesylate Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Rasagiline Mesylate Tablets include Teva Pharmaceutical, Lundbeck, Sun Pharmaceutical, Apotex, Taj Pharma, Mylan, Takeda Pharmaceutical, Sandoz, Intas Pharmaceuticals, Natco Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Rasagiline Mesylate Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rasagiline Mesylate Tablets.
The Rasagiline Mesylate Tablets market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rasagiline Mesylate Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rasagiline Mesylate Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Rasagiline Mesylate Tablets Market Report

Report Metric Details
Report Name Rasagiline Mesylate Tablets Market
Segment by Type
  • 0.5 mg/Pcs
  • 1 mg/Pcs
Segment by Application
  • Under 40 Years Old
  • 40-65 Years Old
  • Above 65 Years Old
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Teva Pharmaceutical, Lundbeck, Sun Pharmaceutical, Apotex, Taj Pharma, Mylan, Takeda Pharmaceutical, Sandoz, Intas Pharmaceuticals, Natco Pharma, Ajanta Pharma, Orchid Pharma, Alkem Laboratories
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Rasagiline Mesylate Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Rasagiline Mesylate Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Rasagiline Mesylate Tablets Market report?

Ans: The main players in the Rasagiline Mesylate Tablets Market are Teva Pharmaceutical, Lundbeck, Sun Pharmaceutical, Apotex, Taj Pharma, Mylan, Takeda Pharmaceutical, Sandoz, Intas Pharmaceuticals, Natco Pharma, Ajanta Pharma, Orchid Pharma, Alkem Laboratories

What are the Application segmentation covered in the Rasagiline Mesylate Tablets Market report?

Ans: The Applications covered in the Rasagiline Mesylate Tablets Market report are Under 40 Years Old, 40-65 Years Old, Above 65 Years Old

What are the Type segmentation covered in the Rasagiline Mesylate Tablets Market report?

Ans: The Types covered in the Rasagiline Mesylate Tablets Market report are 0.5 mg/Pcs, 1 mg/Pcs

1 Rasagiline Mesylate Tablets Market Overview
1.1 Product Definition
1.2 Rasagiline Mesylate Tablets by Type
1.2.1 Global Rasagiline Mesylate Tablets Market Value Comparison by Type (2024 VS 2031)
1.2.2 0.5 mg/Pcs
1.2.3 1 mg/Pcs
1.3 Rasagiline Mesylate Tablets by Application
1.3.1 Global Rasagiline Mesylate Tablets Market Value by Application (2024 VS 2031)
1.3.2 Under 40 Years Old
1.3.3 40-65 Years Old
1.3.4 Above 65 Years Old
1.4 Global Rasagiline Mesylate Tablets Market Size Estimates and Forecasts
1.4.1 Global Rasagiline Mesylate Tablets Revenue 2020-2031
1.4.2 Global Rasagiline Mesylate Tablets Sales 2020-2031
1.4.3 Global Rasagiline Mesylate Tablets Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Rasagiline Mesylate Tablets Market Competition by Manufacturers
2.1 Global Rasagiline Mesylate Tablets Sales Market Share by Manufacturers (2020-2025)
2.2 Global Rasagiline Mesylate Tablets Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Rasagiline Mesylate Tablets Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Rasagiline Mesylate Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Rasagiline Mesylate Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rasagiline Mesylate Tablets, Product Type & Application
2.7 Global Key Manufacturers of Rasagiline Mesylate Tablets, Date of Enter into This Industry
2.8 Global Rasagiline Mesylate Tablets Market Competitive Situation and Trends
2.8.1 Global Rasagiline Mesylate Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Rasagiline Mesylate Tablets Players Market Share by Revenue
2.8.3 Global Rasagiline Mesylate Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Rasagiline Mesylate Tablets Market Scenario by Region
3.1 Global Rasagiline Mesylate Tablets Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Rasagiline Mesylate Tablets Sales by Region: 2020-2031
3.2.1 Global Rasagiline Mesylate Tablets Sales by Region: 2020-2025
3.2.2 Global Rasagiline Mesylate Tablets Sales by Region: 2026-2031
3.3 Global Rasagiline Mesylate Tablets Revenue by Region: 2020-2031
3.3.1 Global Rasagiline Mesylate Tablets Revenue by Region: 2020-2025
3.3.2 Global Rasagiline Mesylate Tablets Revenue by Region: 2026-2031
3.4 North America Rasagiline Mesylate Tablets Market Facts & Figures by Country
3.4.1 North America Rasagiline Mesylate Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Rasagiline Mesylate Tablets Sales by Country (2020-2031)
3.4.3 North America Rasagiline Mesylate Tablets Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Rasagiline Mesylate Tablets Market Facts & Figures by Country
3.5.1 Europe Rasagiline Mesylate Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Rasagiline Mesylate Tablets Sales by Country (2020-2031)
3.5.3 Europe Rasagiline Mesylate Tablets Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rasagiline Mesylate Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Rasagiline Mesylate Tablets Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Rasagiline Mesylate Tablets Sales by Region (2020-2031)
3.6.3 Asia Pacific Rasagiline Mesylate Tablets Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Rasagiline Mesylate Tablets Market Facts & Figures by Country
3.7.1 Latin America Rasagiline Mesylate Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Rasagiline Mesylate Tablets Sales by Country (2020-2031)
3.7.3 Latin America Rasagiline Mesylate Tablets Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rasagiline Mesylate Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Rasagiline Mesylate Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Rasagiline Mesylate Tablets Sales by Country (2020-2031)
3.8.3 Middle East and Africa Rasagiline Mesylate Tablets Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Rasagiline Mesylate Tablets Sales by Type (2020-2031)
4.1.1 Global Rasagiline Mesylate Tablets Sales by Type (2020-2025)
4.1.2 Global Rasagiline Mesylate Tablets Sales by Type (2026-2031)
4.1.3 Global Rasagiline Mesylate Tablets Sales Market Share by Type (2020-2031)
4.2 Global Rasagiline Mesylate Tablets Revenue by Type (2020-2031)
4.2.1 Global Rasagiline Mesylate Tablets Revenue by Type (2020-2025)
4.2.2 Global Rasagiline Mesylate Tablets Revenue by Type (2026-2031)
4.2.3 Global Rasagiline Mesylate Tablets Revenue Market Share by Type (2020-2031)
4.3 Global Rasagiline Mesylate Tablets Price by Type (2020-2031)
5 Segment by Application
5.1 Global Rasagiline Mesylate Tablets Sales by Application (2020-2031)
5.1.1 Global Rasagiline Mesylate Tablets Sales by Application (2020-2025)
5.1.2 Global Rasagiline Mesylate Tablets Sales by Application (2026-2031)
5.1.3 Global Rasagiline Mesylate Tablets Sales Market Share by Application (2020-2031)
5.2 Global Rasagiline Mesylate Tablets Revenue by Application (2020-2031)
5.2.1 Global Rasagiline Mesylate Tablets Revenue by Application (2020-2025)
5.2.2 Global Rasagiline Mesylate Tablets Revenue by Application (2026-2031)
5.2.3 Global Rasagiline Mesylate Tablets Revenue Market Share by Application (2020-2031)
5.3 Global Rasagiline Mesylate Tablets Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Teva Pharmaceutical
6.1.1 Teva Pharmaceutical Company Information
6.1.2 Teva Pharmaceutical Description and Business Overview
6.1.3 Teva Pharmaceutical Rasagiline Mesylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Teva Pharmaceutical Rasagiline Mesylate Tablets Product Portfolio
6.1.5 Teva Pharmaceutical Recent Developments/Updates
6.2 Lundbeck
6.2.1 Lundbeck Company Information
6.2.2 Lundbeck Description and Business Overview
6.2.3 Lundbeck Rasagiline Mesylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Lundbeck Rasagiline Mesylate Tablets Product Portfolio
6.2.5 Lundbeck Recent Developments/Updates
6.3 Sun Pharmaceutical
6.3.1 Sun Pharmaceutical Company Information
6.3.2 Sun Pharmaceutical Description and Business Overview
6.3.3 Sun Pharmaceutical Rasagiline Mesylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sun Pharmaceutical Rasagiline Mesylate Tablets Product Portfolio
6.3.5 Sun Pharmaceutical Recent Developments/Updates
6.4 Apotex
6.4.1 Apotex Company Information
6.4.2 Apotex Description and Business Overview
6.4.3 Apotex Rasagiline Mesylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Apotex Rasagiline Mesylate Tablets Product Portfolio
6.4.5 Apotex Recent Developments/Updates
6.5 Taj Pharma
6.5.1 Taj Pharma Company Information
6.5.2 Taj Pharma Description and Business Overview
6.5.3 Taj Pharma Rasagiline Mesylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Taj Pharma Rasagiline Mesylate Tablets Product Portfolio
6.5.5 Taj Pharma Recent Developments/Updates
6.6 Mylan
6.6.1 Mylan Company Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Rasagiline Mesylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Mylan Rasagiline Mesylate Tablets Product Portfolio
6.6.5 Mylan Recent Developments/Updates
6.7 Takeda Pharmaceutical
6.7.1 Takeda Pharmaceutical Company Information
6.7.2 Takeda Pharmaceutical Description and Business Overview
6.7.3 Takeda Pharmaceutical Rasagiline Mesylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Takeda Pharmaceutical Rasagiline Mesylate Tablets Product Portfolio
6.7.5 Takeda Pharmaceutical Recent Developments/Updates
6.8 Sandoz
6.8.1 Sandoz Company Information
6.8.2 Sandoz Description and Business Overview
6.8.3 Sandoz Rasagiline Mesylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sandoz Rasagiline Mesylate Tablets Product Portfolio
6.8.5 Sandoz Recent Developments/Updates
6.9 Intas Pharmaceuticals
6.9.1 Intas Pharmaceuticals Company Information
6.9.2 Intas Pharmaceuticals Description and Business Overview
6.9.3 Intas Pharmaceuticals Rasagiline Mesylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Intas Pharmaceuticals Rasagiline Mesylate Tablets Product Portfolio
6.9.5 Intas Pharmaceuticals Recent Developments/Updates
6.10 Natco Pharma
6.10.1 Natco Pharma Company Information
6.10.2 Natco Pharma Description and Business Overview
6.10.3 Natco Pharma Rasagiline Mesylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Natco Pharma Rasagiline Mesylate Tablets Product Portfolio
6.10.5 Natco Pharma Recent Developments/Updates
6.11 Ajanta Pharma
6.11.1 Ajanta Pharma Company Information
6.11.2 Ajanta Pharma Description and Business Overview
6.11.3 Ajanta Pharma Rasagiline Mesylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Ajanta Pharma Rasagiline Mesylate Tablets Product Portfolio
6.11.5 Ajanta Pharma Recent Developments/Updates
6.12 Orchid Pharma
6.12.1 Orchid Pharma Company Information
6.12.2 Orchid Pharma Description and Business Overview
6.12.3 Orchid Pharma Rasagiline Mesylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Orchid Pharma Rasagiline Mesylate Tablets Product Portfolio
6.12.5 Orchid Pharma Recent Developments/Updates
6.13 Alkem Laboratories
6.13.1 Alkem Laboratories Company Information
6.13.2 Alkem Laboratories Description and Business Overview
6.13.3 Alkem Laboratories Rasagiline Mesylate Tablets Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Alkem Laboratories Rasagiline Mesylate Tablets Product Portfolio
6.13.5 Alkem Laboratories Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rasagiline Mesylate Tablets Industry Chain Analysis
7.2 Rasagiline Mesylate Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rasagiline Mesylate Tablets Production Mode & Process Analysis
7.4 Rasagiline Mesylate Tablets Sales and Marketing
7.4.1 Rasagiline Mesylate Tablets Sales Channels
7.4.2 Rasagiline Mesylate Tablets Distributors
7.5 Rasagiline Mesylate Tablets Customer Analysis
8 Rasagiline Mesylate Tablets Market Dynamics
8.1 Rasagiline Mesylate Tablets Industry Trends
8.2 Rasagiline Mesylate Tablets Market Drivers
8.3 Rasagiline Mesylate Tablets Market Challenges
8.4 Rasagiline Mesylate Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Teva Pharmaceutical
Lundbeck
Sun Pharmaceutical
Apotex
Taj Pharma
Mylan NV
Takeda Pharmaceutical
Sandoz Inc
Intas Pharmaceuticals
Natco Pharma
Ajanta Pharma
Orchid Pharma
Alkem Laboratories
List of Tables
 Table 1. Global Rasagiline Mesylate Tablets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Rasagiline Mesylate Tablets Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Rasagiline Mesylate Tablets Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Rasagiline Mesylate Tablets Sales (M Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Rasagiline Mesylate Tablets Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Rasagiline Mesylate Tablets Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Rasagiline Mesylate Tablets Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Rasagiline Mesylate Tablets Average Price (USD/K Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Rasagiline Mesylate Tablets, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Rasagiline Mesylate Tablets, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Rasagiline Mesylate Tablets, Product Type & Application
 Table 12. Global Key Manufacturers of Rasagiline Mesylate Tablets, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Rasagiline Mesylate Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rasagiline Mesylate Tablets as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Rasagiline Mesylate Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Rasagiline Mesylate Tablets Sales by Region (2020-2025) & (M Pcs)
 Table 18. Global Rasagiline Mesylate Tablets Sales Market Share by Region (2020-2025)
 Table 19. Global Rasagiline Mesylate Tablets Sales by Region (2026-2031) & (M Pcs)
 Table 20. Global Rasagiline Mesylate Tablets Sales Market Share by Region (2026-2031)
 Table 21. Global Rasagiline Mesylate Tablets Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Rasagiline Mesylate Tablets Revenue Market Share by Region (2020-2025)
 Table 23. Global Rasagiline Mesylate Tablets Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Rasagiline Mesylate Tablets Revenue Market Share by Region (2026-2031)
 Table 25. North America Rasagiline Mesylate Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Rasagiline Mesylate Tablets Sales by Country (2020-2025) & (M Pcs)
 Table 27. North America Rasagiline Mesylate Tablets Sales by Country (2026-2031) & (M Pcs)
 Table 28. North America Rasagiline Mesylate Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Rasagiline Mesylate Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Rasagiline Mesylate Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Rasagiline Mesylate Tablets Sales by Country (2020-2025) & (M Pcs)
 Table 32. Europe Rasagiline Mesylate Tablets Sales by Country (2026-2031) & (M Pcs)
 Table 33. Europe Rasagiline Mesylate Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Rasagiline Mesylate Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Rasagiline Mesylate Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Rasagiline Mesylate Tablets Sales by Region (2020-2025) & (M Pcs)
 Table 37. Asia Pacific Rasagiline Mesylate Tablets Sales by Region (2026-2031) & (M Pcs)
 Table 38. Asia Pacific Rasagiline Mesylate Tablets Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Rasagiline Mesylate Tablets Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Rasagiline Mesylate Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Rasagiline Mesylate Tablets Sales by Country (2020-2025) & (M Pcs)
 Table 42. Latin America Rasagiline Mesylate Tablets Sales by Country (2026-2031) & (M Pcs)
 Table 43. Latin America Rasagiline Mesylate Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Rasagiline Mesylate Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Rasagiline Mesylate Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Rasagiline Mesylate Tablets Sales by Country (2020-2025) & (M Pcs)
 Table 47. Middle East and Africa Rasagiline Mesylate Tablets Sales by Country (2026-2031) & (M Pcs)
 Table 48. Middle East and Africa Rasagiline Mesylate Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Rasagiline Mesylate Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Rasagiline Mesylate Tablets Sales (M Pcs) by Type (2020-2025)
 Table 51. Global Rasagiline Mesylate Tablets Sales (M Pcs) by Type (2026-2031)
 Table 52. Global Rasagiline Mesylate Tablets Sales Market Share by Type (2020-2025)
 Table 53. Global Rasagiline Mesylate Tablets Sales Market Share by Type (2026-2031)
 Table 54. Global Rasagiline Mesylate Tablets Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Rasagiline Mesylate Tablets Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Rasagiline Mesylate Tablets Revenue Market Share by Type (2020-2025)
 Table 57. Global Rasagiline Mesylate Tablets Revenue Market Share by Type (2026-2031)
 Table 58. Global Rasagiline Mesylate Tablets Price (USD/K Pcs) by Type (2020-2025)
 Table 59. Global Rasagiline Mesylate Tablets Price (USD/K Pcs) by Type (2026-2031)
 Table 60. Global Rasagiline Mesylate Tablets Sales (M Pcs) by Application (2020-2025)
 Table 61. Global Rasagiline Mesylate Tablets Sales (M Pcs) by Application (2026-2031)
 Table 62. Global Rasagiline Mesylate Tablets Sales Market Share by Application (2020-2025)
 Table 63. Global Rasagiline Mesylate Tablets Sales Market Share by Application (2026-2031)
 Table 64. Global Rasagiline Mesylate Tablets Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Rasagiline Mesylate Tablets Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Rasagiline Mesylate Tablets Revenue Market Share by Application (2020-2025)
 Table 67. Global Rasagiline Mesylate Tablets Revenue Market Share by Application (2026-2031)
 Table 68. Global Rasagiline Mesylate Tablets Price (USD/K Pcs) by Application (2020-2025)
 Table 69. Global Rasagiline Mesylate Tablets Price (USD/K Pcs) by Application (2026-2031)
 Table 70. Teva Pharmaceutical Company Information
 Table 71. Teva Pharmaceutical Description and Business Overview
 Table 72. Teva Pharmaceutical Rasagiline Mesylate Tablets Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)
 Table 73. Teva Pharmaceutical Rasagiline Mesylate Tablets Product
 Table 74. Teva Pharmaceutical Recent Developments/Updates
 Table 75. Lundbeck Company Information
 Table 76. Lundbeck Description and Business Overview
 Table 77. Lundbeck Rasagiline Mesylate Tablets Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)
 Table 78. Lundbeck Rasagiline Mesylate Tablets Product
 Table 79. Lundbeck Recent Developments/Updates
 Table 80. Sun Pharmaceutical Company Information
 Table 81. Sun Pharmaceutical Description and Business Overview
 Table 82. Sun Pharmaceutical Rasagiline Mesylate Tablets Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)
 Table 83. Sun Pharmaceutical Rasagiline Mesylate Tablets Product
 Table 84. Sun Pharmaceutical Recent Developments/Updates
 Table 85. Apotex Company Information
 Table 86. Apotex Description and Business Overview
 Table 87. Apotex Rasagiline Mesylate Tablets Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)
 Table 88. Apotex Rasagiline Mesylate Tablets Product
 Table 89. Apotex Recent Developments/Updates
 Table 90. Taj Pharma Company Information
 Table 91. Taj Pharma Description and Business Overview
 Table 92. Taj Pharma Rasagiline Mesylate Tablets Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)
 Table 93. Taj Pharma Rasagiline Mesylate Tablets Product
 Table 94. Taj Pharma Recent Developments/Updates
 Table 95. Mylan Company Information
 Table 96. Mylan Description and Business Overview
 Table 97. Mylan Rasagiline Mesylate Tablets Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)
 Table 98. Mylan Rasagiline Mesylate Tablets Product
 Table 99. Mylan Recent Developments/Updates
 Table 100. Takeda Pharmaceutical Company Information
 Table 101. Takeda Pharmaceutical Description and Business Overview
 Table 102. Takeda Pharmaceutical Rasagiline Mesylate Tablets Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)
 Table 103. Takeda Pharmaceutical Rasagiline Mesylate Tablets Product
 Table 104. Takeda Pharmaceutical Recent Developments/Updates
 Table 105. Sandoz Company Information
 Table 106. Sandoz Description and Business Overview
 Table 107. Sandoz Rasagiline Mesylate Tablets Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)
 Table 108. Sandoz Rasagiline Mesylate Tablets Product
 Table 109. Sandoz Recent Developments/Updates
 Table 110. Intas Pharmaceuticals Company Information
 Table 111. Intas Pharmaceuticals Description and Business Overview
 Table 112. Intas Pharmaceuticals Rasagiline Mesylate Tablets Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)
 Table 113. Intas Pharmaceuticals Rasagiline Mesylate Tablets Product
 Table 114. Intas Pharmaceuticals Recent Developments/Updates
 Table 115. Natco Pharma Company Information
 Table 116. Natco Pharma Description and Business Overview
 Table 117. Natco Pharma Rasagiline Mesylate Tablets Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)
 Table 118. Natco Pharma Rasagiline Mesylate Tablets Product
 Table 119. Natco Pharma Recent Developments/Updates
 Table 120. Ajanta Pharma Company Information
 Table 121. Ajanta Pharma Description and Business Overview
 Table 122. Ajanta Pharma Rasagiline Mesylate Tablets Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)
 Table 123. Ajanta Pharma Rasagiline Mesylate Tablets Product
 Table 124. Ajanta Pharma Recent Developments/Updates
 Table 125. Orchid Pharma Company Information
 Table 126. Orchid Pharma Description and Business Overview
 Table 127. Orchid Pharma Rasagiline Mesylate Tablets Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)
 Table 128. Orchid Pharma Rasagiline Mesylate Tablets Product
 Table 129. Orchid Pharma Recent Developments/Updates
 Table 130. Alkem Laboratories Company Information
 Table 131. Alkem Laboratories Description and Business Overview
 Table 132. Alkem Laboratories Rasagiline Mesylate Tablets Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2020-2025)
 Table 133. Alkem Laboratories Rasagiline Mesylate Tablets Product
 Table 134. Alkem Laboratories Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Rasagiline Mesylate Tablets Distributors List
 Table 138. Rasagiline Mesylate Tablets Customers List
 Table 139. Rasagiline Mesylate Tablets Market Trends
 Table 140. Rasagiline Mesylate Tablets Market Drivers
 Table 141. Rasagiline Mesylate Tablets Market Challenges
 Table 142. Rasagiline Mesylate Tablets Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Rasagiline Mesylate Tablets
 Figure 2. Global Rasagiline Mesylate Tablets Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Rasagiline Mesylate Tablets Market Share by Type: 2024 & 2031
 Figure 4. 0.5 mg/Pcs Product Picture
 Figure 5. 1 mg/Pcs Product Picture
 Figure 6. Global Rasagiline Mesylate Tablets Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Rasagiline Mesylate Tablets Market Share by Application: 2024 & 2031
 Figure 8. Under 40 Years Old
 Figure 9. 40-65 Years Old
 Figure 10. Above 65 Years Old
 Figure 11. Global Rasagiline Mesylate Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Rasagiline Mesylate Tablets Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Rasagiline Mesylate Tablets Sales (2020-2031) & (M Pcs)
 Figure 14. Global Rasagiline Mesylate Tablets Average Price (USD/K Pcs) & (2020-2031)
 Figure 15. Rasagiline Mesylate Tablets Report Years Considered
 Figure 16. Rasagiline Mesylate Tablets Sales Share by Manufacturers in 2024
 Figure 17. Global Rasagiline Mesylate Tablets Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Rasagiline Mesylate Tablets Players: Market Share by Revenue in Rasagiline Mesylate Tablets in 2024
 Figure 19. Rasagiline Mesylate Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Rasagiline Mesylate Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Rasagiline Mesylate Tablets Sales Market Share by Country (2020-2031)
 Figure 22. North America Rasagiline Mesylate Tablets Revenue Market Share by Country (2020-2031)
 Figure 23. United States Rasagiline Mesylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Rasagiline Mesylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Rasagiline Mesylate Tablets Sales Market Share by Country (2020-2031)
 Figure 26. Europe Rasagiline Mesylate Tablets Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Rasagiline Mesylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Rasagiline Mesylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Rasagiline Mesylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Rasagiline Mesylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Rasagiline Mesylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Rasagiline Mesylate Tablets Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Rasagiline Mesylate Tablets Revenue Market Share by Region (2020-2031)
 Figure 34. China Rasagiline Mesylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Rasagiline Mesylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Rasagiline Mesylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Rasagiline Mesylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Rasagiline Mesylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Rasagiline Mesylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Rasagiline Mesylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Rasagiline Mesylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Rasagiline Mesylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Rasagiline Mesylate Tablets Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Rasagiline Mesylate Tablets Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Rasagiline Mesylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Rasagiline Mesylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Rasagiline Mesylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Rasagiline Mesylate Tablets Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Rasagiline Mesylate Tablets Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Rasagiline Mesylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Rasagiline Mesylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Rasagiline Mesylate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Rasagiline Mesylate Tablets by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Rasagiline Mesylate Tablets by Type (2020-2031)
 Figure 55. Global Rasagiline Mesylate Tablets Price (USD/K Pcs) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Rasagiline Mesylate Tablets by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Rasagiline Mesylate Tablets by Application (2020-2031)
 Figure 58. Global Rasagiline Mesylate Tablets Price (USD/K Pcs) by Application (2020-2031)
 Figure 59. Rasagiline Mesylate Tablets Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Azilect Market Research Report 2024
Global Rasagiline Mesylate API Market Research Report 2025
Global Mirtazapine Tablets Market Research Report 2024
Zonisamide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Aliskiren Market Insights Forecast to 2030
Global Betahistine Mesylate Tablets Market Research Report 2025
Global Levomilnacipran Tablets Market Research Report 2024
Global Aripiprazole Drug Market Insights Forecast to 2030
Global Osimertinib Mesylate Tablets Market Research Report 2024
Global Carbidopa Levodopa Tablets Market Research Report 2025
Global Raibizumab Biosimilars Market Research Report 2025
Global Levodopa Tablets Market Research Report 2024
Global Tofacitinib Tablets Market Research Report 2024
Global Moclobemide Tablet Market Research Report 2025
Medical Deferoxamine Mesylate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Memantine Hydrochloride Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Dementia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Belumosudil Mesylate Tablets Market Research Report 2024
Global Repaglinide Tablets Market Research Report 2024
Global Reboxetine Mesylate Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions